Actualités Medicure Inc - MPH | Actions TSX Venture Exchange

Medicure reiterates its commitment to providing exceptional access to its branded pitavastatin (zypitamag) to people living with hiv

MEDICURE REITERATES ITS COMMITMENT TO PROVIDING EXCEPTIONAL ACCESS TO ITS BRANDED PITAVASTATIN (ZYPITAMAG) TO PEOPLE...

Algernon Pharmaceuticals Announces New Chief Financial Officer

VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company”...

Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer

LONDON and REDWOOD CITY, Calif. and HOUSTON, Texas, April 30, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group...

Mereo BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference

LONDON and REDWOOD City, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO...

Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights

-- Ultragenyx Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta Further...

Mereo BioPharma to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference

LONDON and REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO...

Mereo BioPharma Group plc Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriter...

LONDON and REDWOOD CITY, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO...

Mereo BioPharma Group plc Announces Pricing of Public Offering of American Depositary Shares

LONDON and REDWOOD CITY, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO...

Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares

LONDON and REDWOOD CITY, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO...

Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta

Clinical-stage monoclonal antibody in development for rare genetic bone disease that builds on Ultragenyx’s...

Mereo BioPharma Provides Update on AIM Delisting and Continued Listing of its ADSs on Nasdaq, and Provides Update on agreemen...

LONDON and REDWOOD CITY, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medicure Inc (MPH)

Outils de qualité professionnelle, pour des investisseurs individuels.

MPH Actualités

Medicure reiterates its commitment to providing exceptional access to its branded pitavastatin (zypitamag) to people living with hiv

Algernon Pharmaceuticals Announces New Chief Financial Officer

Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer

Mereo BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference

Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights

Mereo BioPharma to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference

Mereo BioPharma Group plc Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriter...

Mereo BioPharma Group plc Announces Pricing of Public Offering of American Depositary Shares

Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares

Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta

Mereo BioPharma Provides Update on AIM Delisting and Continued Listing of its ADSs on Nasdaq, and Provides Update on agreemen...

Mereo BioPharma Appoints Suba Krishnan, M.D. as Senior Vice President of Clinical Development

Mereo BioPharma to Hold Virtual R&D Day on Tuesday, November 24, 2020

Mereo BioPharma to Present at the Stifel 2020 Virtual Healthcare Conference

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medicure Inc (MPH) Actualités

Medicure Inc (MPH)

Outils de qualité professionnelle, pour des investisseurs individuels.

MPH Actualités

Medicure reiterates its commitment to providing exceptional access to its branded pitavastatin (zypitamag) to people living with hiv

Algernon Pharmaceuticals Announces New Chief Financial Officer

Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer

Mereo BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference

Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights

Mereo BioPharma to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference

Mereo BioPharma Group plc Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriter...

Mereo BioPharma Group plc Announces Pricing of Public Offering of American Depositary Shares

Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares

Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta

Mereo BioPharma Provides Update on AIM Delisting and Continued Listing of its ADSs on Nasdaq, and Provides Update on agreemen...

Mereo BioPharma Appoints Suba Krishnan, M.D. as Senior Vice President of Clinical Development

Mereo BioPharma to Hold Virtual R&D Day on Tuesday, November 24, 2020

Mereo BioPharma to Present at the Stifel 2020 Virtual Healthcare Conference

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités